NP33922 Ranibizumab

A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) ("NSS")

Source
Find a Tender
Type
Framework (Goods)
Duration
not specified
Value
£12M
Sector
HEALTH
Published
10 Jun 2022
Delivery
not specified
Deadline
n/a

Concepts

Location

United Kingdom: All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014

Geochart for 1 buyers and 2 suppliers
NHS National Services Scotland NSS
Teva
Novartis Pharmaceuticals
+−
Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

1 buyer

2 suppliers

Description

Supply of ranibizumab injections to NHS Scotland.

Total Quantity or Scope

Supply of ranibizumab 1.65mg/0.165ml solution for injection pre-filled syringes and ranibizumab 2.3mg/0.23ml solution for injection vials to NHS Scotland. The Authority has awarded this framework as an unranked multi-supplier framework per line to two (2) Framework Participants.

Award Detail

1 Teva (Castleford)
  • Reference: 015999-2022-1
  • Value: £11,706,517 [share]
  • Awarded to group of suppliers.
2 Novartis Pharmaceuticals (Frimley)
  • Reference: 015999-2022-1
  • Value: £11,706,517 [share]
  • Awarded to group of suppliers.

Award Criteria

Supply Chain 5
price 95

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

Other Information

** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.I.7 and, Section V.2.4 covers the nine (9) month contract duration and the thirty-six (36) month extension period of the framework agreement. (SC Ref:696391)

Reference

Domains